# Formal Meetings Between the FDA and Sponsors or Applicants of BsUFA Products Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/formal-meetings-between-the-fda-and-sponsors-or-applicants-of-bsufa-products-guidance-for-industry/8a1d80ed-d462-41f3-b1cd-7df78736a49b

> FDA guidance document: Formal Meetings Between the FDA and Sponsors or Applicants of BsUFA Products Guidance for Industry. Issue date: July 18, 2025. Get complete insights and analysis.

---

## Details

- Title: Formal Meetings Between the FDA and Sponsors or Applicants of BsUFA Products Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2025-07-18
- Last Changed: 2025-07-18
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2018-D-1922">FDA-2018-D-1922</a>

## Related Documents

- [Q14 Analytical Procedure Development](https://www.globalkeysolutions.net/guidances/guidance-document/q14-analytical-procedure-development/7f445a67-e90c-4c67-a0c6-958d21e1d405)
- [Best Practices for Communication Between IND Sponsors and FDA During Drug Development](https://www.globalkeysolutions.net/guidances/good-review-practices/best-practices-for-communication-between-ind-sponsors-and-fda-during-drug-development/2c093434-6b20-4df3-af2a-d7af81ab3fd8)
- [Pediatric Study Plans: Content of and Process for Submitting Initial Pediatric Study Plans and Amended Initial Pediatric Study Plans](https://www.globalkeysolutions.net/guidances/guidance-document/pediatric-study-plans-content-of-and-process-for-submitting-initial-pediatric-study-plans-and-amended-initial-pediatric-study-plans/863eefe3-8c96-4abe-a49e-8317e8bfc2b3)